Journal of Nuclear Medicine · 2016 · 1K citations · 16 references
Targeted α-therapy with <sup>225</sup>Ac-PSMA-617, although still experimental, obviously has strong potential to significantly benefit advanced-stage prostate cancer patients.
16
George Sgouros, John C. Roeske, Michael R. McDevitt et al. · Journal of Nuclear Medicine · 2010 · 504 citations · Full text
Radiation Exposure, α-Particle Emitters, Alpha-particle Emitter Therapy +25
Tumor Therapy with Targeted Atomic Nanogenerators
Michael R. McDevitt, Dangshe Ma, Lawrence Lai et al. · Science · 2001 · 501 citations